Latest

psychopharmacology

This shows a pink brain and a blue brain.

·February 12, 2024·7 min read

Ketamine’s Effects Diverge by Sex

Ketamine's effects on depression and pain, and its interaction with opioid pathways, significantly differ between sexes. In a detailed rat study, the team found that blocking opioid receptors nullified ketamine's impact only in males, suggesting a complex interplay between ketamine, opioid systems, and sex hormones.

Featured Neuroscience Psychology

·February 8, 2024·10 min read

Ketamine’s Leap from Fringe to Mainstream in Depression Treatment

A new study involving 74 participants, has demonstrated significant promise for intravenous ketamine in treating severe depression and bipolar disorder, conditions often resistant to traditional therapies. This research indicates that after just three ketamine infusions over 11 days, 52% of the participants achieved remission, with half of those frequently experiencing suicidal thoughts witnessing a dramatic decline in such impulses.

Featured Neuroscience Psychology

·February 7, 2024·3 min read

AI Predicts Antidepressant Success in a Week

Researchers developed an AI algorithm that, by analyzing brain scans and clinical information, can predict within a week whether an antidepressant will work for patients with major depression disorder. This method could potentially avoid unnecessary prescriptions of sertraline, a commonly used antidepressant, by identifying non-responders early, thus offering better patient care and reducing side effects.

Featured Neuroscience Psychology

·January 16, 2024·6 min read

Emotional and Social Toll of Antidepressant Withdrawal

New research reveals that coming off antidepressants like Prozac can cause not only physical symptoms but also emotional, cognitive, and social difficulties. The study involved in-depth interviews with 20 individuals who attempted to withdraw from SSRIs in the past year, highlighting the complex challenges they faced, including emotional overwhelm, reduced enjoyment in social situations, and a feeling of detachment.

Featured Neuroscience Psychology

·January 5, 2024·6 min read

Psychoactive Ibogaine and Magnesium Show Promise for PTSD

Ibogaine, a plant-based psychoactive drug combined with magnesium, effectively reduces PTSD, anxiety, and depression in veterans with traumatic brain injuries (TBI). The study, involving 30 U.S. special forces veterans, showed significant and lasting improvements in mental health and functioning post-treatment.

This shows a person surrounded by pills.

Featured Neuroscience Psychology

·January 3, 2024·4 min read

Power of Beliefs on Brain and Drug Dosing Behavior

Researchers discovered that a person's beliefs about drugs can influence their brain activity and behavior similarly to pharmacological effects. Focusing on beliefs about nicotine, the study revealed that human beliefs have a precise and dose-dependent influence on the brain, which can be crucial for understanding addiction and various disorders.

Featured Neuroscience Psychology

·November 27, 2023·6 min read

Ayurvedic Plants Boost Stress and Depression Resilience

Researchers discovered that chronic stress induces depression-like behaviors in fruit flies, Drosophila melanogaster, affecting their motivation and activity. The study found that Ayurvedic medicinal plants, particularly Withania somnifera (ashwagandha) and Centella asiatica, can improve the flies' resilience to chronic stress when used prophylactically.

Featured Neuroscience Psychology

·November 11, 2023·2 min read

Unraveling Psychedelics’ Potential in Mental Health

Research delves into the potential of psychedelics like psilocybin for treating psychiatric disorders. Studies show varying effects of psilocybin on fear learning in rats and mice, dependent on sex and dosage, and its potential to alleviate nicotine withdrawal in mice.

Featured Neuroscience Psychology

·October 19, 2023·3 min read

Xanax’s Efficacy Questioned

Researchers have discovered discrepancies in the efficacy of alprazolam (Xanax XR), a widely prescribed benzodiazepine sedative, when analyzing both published and unpublished clinical trial data. The study found that only one of the five FDA-reviewed trials showed a clearly positive outcome.

Featured Neuroscience Psychology

·October 19, 2023·6 min read

Does Drug Effect or Power of Belief Explain Ketamine’s Antidepressant Effect?

Researchers conducted a unique study to uncover the efficacy of ketamine in treating depression, bypassing its unmistakable psychedelic effects by administering it during surgery. Surprisingly, both the ketamine and placebo groups showed substantial improvement in depression symptoms.

Featured Neuroscience Psychology

·October 3, 2023·5 min read

Psilocybin Microdosing Promising for Mental Health Disorders

Researchers delve into the therapeutic potential of psilocybin microdosing, exploring its influence on stress resilience and compulsive behaviors in rats. While high-dose psilocybin therapy has been scrutinized for psychiatric treatment applications, this study focuses on low, repeated doses—commonly known as 'microdosing'—and its burgeoning popularity in self-medication narratives online.

This shows a woman talking to her therapist.

Featured Neuroscience Psychology

·October 2, 2023·6 min read

MDMA Makes People Feel More Connected During Conversations

Researchers shed light on MDMA's potential to foster feelings of connection in controlled environments. Their study reveals that individuals on MDMA or methamphetamine felt more connected during conversations compared to those on a placebo.